Completed OBSERVATIONAL NCT03557268

Pubertal Blockade and Hormone Therapy in Transgender Youth (PUBErTY)

Effects of Pubertal Blockade and Hormone Therapy on Cardiometabolic Risk Markers in Transgender Adolescents

Sponsor: University of Colorado, Denver

Conditions Gender Dysphoria Gender Identity Gender Identity Disorder in Adolescence and Adulthood

Updated 9 times since 2018 Last updated: Sep 28, 2020 Started: Jun 19, 2018 Primary completion: Sep 9, 2020 Completion: Sep 9, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Gender Dysphoria and Gender Identity and is currently completed. University of Colorado, Denver leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Oct 2020 — Nov 2020 [monthly]

Completed

Status: Recruiting → Completed
Oct 2019 — Oct 2020 [monthly]

Recruiting
Aug 2018 — Oct 2019 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jul 2018 — Aug 2018 [monthly]

Not Yet Recruiting

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Colorado, Denver

Data source: University of Colorado, Denver

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aurora, United States